These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 29534837)

  • 21. 3D Printing: an appealing technology for the manufacturing of solid oral dosage forms.
    Pitzanti G; Mathew E; Andrews GP; Jones DS; Lamprou DA
    J Pharm Pharmacol; 2022 Oct; 74(10):1427-1449. PubMed ID: 34529072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rise of the (3D printing) machines in healthcare.
    Jewell CM; Stones JA
    Int J Pharm; 2024 Aug; 661():124462. PubMed ID: 39002819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges.
    Seoane-Viaño I; Januskaite P; Alvarez-Lorenzo C; Basit AW; Goyanes A
    J Control Release; 2021 Apr; 332():367-389. PubMed ID: 33652114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D printed implantable drug delivery devices for women's health: Formulation challenges and regulatory perspective.
    Al-Litani K; Ali T; Robles Martinez P; Buanz A
    Adv Drug Deliv Rev; 2023 Jul; 198():114859. PubMed ID: 37149039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRINTING TECHNIQUES: RECENT DEVELOPMENTS IN PHARMACEUTICAL TECHNOLOGY.
    Jamroz W; Kurek M; Lyszczarz E; Brniak W; Jachowicz R
    Acta Pol Pharm; 2017 May; 74(3):753-763. PubMed ID: 29513944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling drug release with additive manufacturing-based solutions.
    Patel SK; Khoder M; Peak M; Alhnan MA
    Adv Drug Deliv Rev; 2021 Jul; 174():369-386. PubMed ID: 33895213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient acceptability of 3D printed medicines.
    Goyanes A; Scarpa M; Kamlow M; Gaisford S; Basit AW; Orlu M
    Int J Pharm; 2017 Sep; 530(1-2):71-78. PubMed ID: 28750894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D printing: Principles and pharmaceutical applications of selective laser sintering.
    Awad A; Fina F; Goyanes A; Gaisford S; Basit AW
    Int J Pharm; 2020 Aug; 586():119594. PubMed ID: 32622811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D printing for personalised medicines: implications for policy and practice.
    Englezos K; Wang L; Tan ECK; Kang L
    Int J Pharm; 2023 Mar; 635():122785. PubMed ID: 36849040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective laser sintering 3D printing - an overview of the technology and pharmaceutical applications.
    Charoo NA; Barakh Ali SF; Mohamed EM; Kuttolamadom MA; Ozkan T; Khan MA; Rahman Z
    Drug Dev Ind Pharm; 2020 Jun; 46(6):869-877. PubMed ID: 32364418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives on 3D printed personalized medicines for pediatrics.
    Tong H; Zhang J; Ma J; Zhang J
    Int J Pharm; 2024 Mar; 653():123867. PubMed ID: 38310991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrusion-Based 3D Printing for Pharmaceuticals: Contemporary Research and Applications.
    Algahtani MS; Mohammed AA; Ahmad J
    Curr Pharm Des; 2018; 24(42):4991-5008. PubMed ID: 30636584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges.
    Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S
    Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D printing of tablets containing multiple drugs with defined release profiles.
    Khaled SA; Burley JC; Alexander MR; Yang J; Roberts CJ
    Int J Pharm; 2015 Oct; 494(2):643-650. PubMed ID: 26235921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D printing in pharmaceuticals: An emerging technology full of challenges.
    Wadher K; Trivedi R; Wankhede N; Kale M; Umekar M
    Ann Pharm Fr; 2021 Mar; 79(2):107-118. PubMed ID: 32853575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks.
    Trenfield SJ; Xian Tan H; Awad A; Buanz A; Gaisford S; Basit AW; Goyanes A
    Int J Pharm; 2019 Aug; 567():118443. PubMed ID: 31212052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fused-filament 3D printing (3DP) for fabrication of tablets.
    Goyanes A; Buanz AB; Basit AW; Gaisford S
    Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concept and Evolution in 3-D Printing for Excellence in Healthcare.
    Sinha P; Lahare P; Sahu M; Cimler R; Schnitzer M; Hlubenova J; Hudak R; Singh N; Gupta B; Kuca K
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38265395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
    Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
    Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.